Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants
Development of Transcutaneous Bilirubin Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants: a Multicenter Study in China
1 other identifier
observational
19,601
1 country
16
Brief Summary
Thirteen hospitals in China will participate in the study, which aims to provide data on transcutaneous bilirubin (TcB) levels for the first 168 hr after birth in term and late-preterm neonates, and develop an hour-specific TcB nomogram. The investigators hypothesize that the hour-specific TcB nomogram can predict neonatal hyperbilirubinemia in term and late-preterm Chinese infants, and plan appropriate follow-up for hyperbilirubinemia in newborns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Shorter than P25 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 2, 2013
CompletedFirst Posted
Study publicly available on registry
January 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedOctober 28, 2014
October 1, 2014
11 months
January 2, 2013
October 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of transcutaneous bilirubin levels from baseline to each postpartum examination up to 168 hr after birth
During the first postnatal day, transcutaneous bilirubin (TcB) measures were performed at 12-hour time intervals up to the age of 168 hr. TcB data are used to develop an hour-specific TcB nomogram.
Every 12 hr for 168 hr.
Secondary Outcomes (1)
Predictive ability of an hour-specific TcB nomogram
At the 28 days after birth
Interventions
Device: JM-103 (Minolta, Osaka, Japan, jaundice assessment) Procedure: Transcutaneous bilirubinometry (TcB)
Eligibility Criteria
Term or late-preterm newborn infants from thirteen hospital in China were recruited.
You may qualify if:
- Term or late-preterm newborn infants with GAs of ≥35 weeks and birth weights of ≥2,000 g were included.
You may not qualify if:
- All sick newborn infants who were admitted to the intensive care unit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nanjing Medical Universitylead
- Children's Hospital of Fudan Universitycollaborator
- Nanjing Maternity and Child Health Care Hospitalcollaborator
- First Affiliated Hospital of Harbin Medical Universitycollaborator
- Jinlin Provincial Maternal and Child Health Hospitalcollaborator
- Peking University Third Hospitalcollaborator
- Inner Mongolia Maternal and Child Health Care Hospitalcollaborator
- Shanxi Provincial Maternity and Children's Hospitalcollaborator
- Obstetrics & Gynecology Hospital of Fudan Universitycollaborator
- The First Affiliated Hospital of Zhengzhou Universitycollaborator
- Guangdong Women and Children Hospitalcollaborator
- Guangxi Maternal and Child Health Hospitalcollaborator
- First Affiliated Hospital of Xinjiang Medical Universitycollaborator
- Sichuan Provincial People's Hospitalcollaborator
- Guiyang Maternity and Child Health Care Hospitalcollaborator
Study Sites (16)
Guangdong Maternal and Children's Hospital, Guangzhou Medical College
Guangzhou, Guangdong, 510010, China
Guangxi Maternal and Child Health Hospital
Liuchow, Guangxi, 530003, China
Guiyang Maternal and Child Health Hospital
Guiyang, Guizhou, 550003, China
The First Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 410100, China
Inner Mongolia Maternal and Child Health Care Hospital
Hohhot, Inner Mongolia, 010020, China
Nanjing Maternity and Child Health Care Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210004, China
Jinlin Provincial Maternal and Child Health Hospital
Changchun, Jilin, 130021, China
Shaanxi Provincial Maternal and Child Health Hospital
Taiyuan, Shaanxi, 300013, China
Shaanxi Provincial Maternal and Child Health Hospital
Xi'an, Shaanxi, 710003, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
The First Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
The Third Hospital of Peking University
Beijing, 100191, China
Gynecology and Obstetrics Hospital, Fudan University
Shanghai, 200011, China
Children's Hospital of Fudan University
Shanghai, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chao Chen, PhD
Children's Hospital of Fudan University
- STUDY DIRECTOR
Shuping Han, PhD
Nanjing Maternity and Child Health Care Hospital
- PRINCIPAL INVESTIGATOR
Zhangbin Yu, PhD
Nanjing Maternity and Child Health Care Hospital
- PRINCIPAL INVESTIGATOR
Chunming Jiang, PhD
First Affiliated Hospital of Harbin Medical University
- PRINCIPAL INVESTIGATOR
Yan Gao, PhD
Jinlin Provincial Maternal and Child Health Hospital
- PRINCIPAL INVESTIGATOR
Xiaomei Tong, PhD
Peking University Third Hospital
- PRINCIPAL INVESTIGATOR
Meihua Pu, PhD
Peking University Third Hospital
- PRINCIPAL INVESTIGATOR
Hongyun Wang, PhD
Inner Mongolia Maternal and Child Health Care Hospital
- PRINCIPAL INVESTIGATOR
Kezhan Liu, PhD
Shanxi Provincial Maternity and Children's Hospital
- PRINCIPAL INVESTIGATOR
Jin Wang, PhD
Children's Hospital of Fudan University
- PRINCIPAL INVESTIGATOR
Jimei Wang, PhD
Obstetrics & Gynecology Hospital of Fudan University
- PRINCIPAL INVESTIGATOR
Xiuyong Cheng, PhD
The First Affiliated Hospital of Zhengzhou University
- PRINCIPAL INVESTIGATOR
Jie Yang, PhD
Guangdong Women and Children Hospital
- PRINCIPAL INVESTIGATOR
Qiufen Wei, PhD
Guangxi Maternal and Child Health Hospital
- PRINCIPAL INVESTIGATOR
Zhankui Li, PhD
Shanxi Provincial Maternity and Children's Hospital
- PRINCIPAL INVESTIGATOR
Mingxia Li, PhD
First Affiliated Hospital of Xinjiang Medical University
- PRINCIPAL INVESTIGATOR
Ling Liu, PhD
Guiyang Maternity and Child Health Care Hospital
- PRINCIPAL INVESTIGATOR
Xiaofan Sun, MD
Nanjing Maternity and Child Health Care Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 2, 2013
First Posted
January 9, 2013
Study Start
January 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
October 28, 2014
Record last verified: 2014-10